EUVIMEDEUVIMED entdecken
Crossref

Synthesis, Anti‐Fibrotic Activity, and Density Functional Theory Calculations of Novel Carboxylic Acid Analogs Containing Pyrrole and Imidazole Rings

Hiruni Nilshi Indeevarie Abeysiriwardhana iD, Jin-Hyuk Choi, Ayusha Malla, Yoongho Lim, Chulhun Park, Sang-Soep Nahm, Moonjae Cho iD

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Hiruni Nilshi Indeevarie Abeysiriwardhana und 6 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju-si, Republic of Korea. Hauptthemen laut MEDLINE: Imidazoles, Pyrroles, Carboxylic Acids, Antifibrotic Agents. Die Arbeit nennt 70 Literaturangaben. Gefördert von: Ministry of Education, Ministry of SMEs and Startups.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease with limited treatment options and poor prognosis. Current therapies, Pirfenidone and Nintedanib, slow disease progression but cannot reverse established fibrosis, underscoring the urgent need for innovative strategies. Oxidative stress and hypoxia‐inducible factor‐1α (HIF‐1α) signaling are central to IPF pathogenesis, where the interplay between reactive oxygen species (ROS), TGF‐β1, and stabilized HIF‐1α forms a self‐perpetuating loop that promotes fibroblast activation and extracellular matrix (ECM) deposition. To interrupt this pathological cycle, we rationally designed and synthesized four small molecules, two imidazole‐ and two pyrrole‐based derivatives, with dual antioxidants and HIF‐1α inhibitory potential. Their antioxidant potential was assessed using DPPH and DCFDA assays, while density functional theory (DFT) calculations and ADME profiling confirmed their chemical stability and drug‐likeness. In vitro screening identified compound 2a as the lead candidate based on its superior ability to inhibit HIF‐1α and suppress fibrotic markers, including collagen III, fibronectin, and vimentin, in TGF‐β1‐stimulated A549 and MRC‐5 cells. In vivo, 2a significantly attenuated collagen and fibronectin accumulation in a bleomycin‐induced pulmonary fibrosis model. Mechanistically, 2a inhibited phosphorylation of Smad3 and ERK, implicating modulation of both Smad and non‐Smad pathways in its anti‐fibrotic effects. These findings position compound 2a as a promising dual‐targeted therapeutic candidate for IPF, capable of disrupting the ROS–TGF‐β1–HIF‐1α axis and addressing key unmet clinical needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImidazolesPyrrolesCarboxylic AcidsAntifibrotic AgentsHumansAnimalsDensity Functional TheoryHypoxia-Inducible Factor 1, alpha SubunitIdiopathic Pulmonary FibrosisTransforming Growth Factor beta1MiceReactive Oxygen SpeciesAntioxidantsA549 CellsCell Line

Stichwörter der Autor:innen

antioxidativeanti‐fibrotichypoxia‐inducible factor‐1αimidazolepyrrole

Substanzen

ImidazolesPyrrolesHypoxia-Inducible Factor 1, alpha SubunitCarboxylic AcidsTransforming Growth Factor beta1Antifibrotic AgentsReactive Oxygen SpeciesAntioxidantsimidazole

Autor:innen und Institutionen

  • Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju-si, Republic of Korea.
  • Department of Biochemistry, School of Medicine, Jeju National University, Jeju-si, Republic of Korea.
  • ACHEMBIO Inc, Jeju-si, Republic of Korea.
  • Division of Bioscience and Biotechnology, Konkuk University, Seoul, Republic of Korea.
  • College of Pharmacy, Jeju National University, Jeju-si, Republic of Korea.
  • Department of Veterinary Medicine, College of Veterinary Medicine, Konkuk University, Seoul, Republic of Korea.

ORCID-Profile: Hiruni Nilshi Indeevarie Abeysiriwardhana, Moonjae Cho

Förderung

  • Ministry of Education
  • Ministry of SMEs and Startups

Zitieren

APA

Abeysiriwardhana, H. N. I., Choi, J. H., Malla, A., Lim, Y., Park, C., Nahm, S. S., & Cho, M. (2025). Synthesis, Anti‐Fibrotic Activity, and Density Functional Theory Calculations of Novel Carboxylic Acid Analogs Containing Pyrrole and Imidazole Rings. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70163

Vancouver

Abeysiriwardhana HNI, Choi JH, Malla A, Lim Y, Park C, Nahm SS, et al. Synthesis, Anti‐Fibrotic Activity, and Density Functional Theory Calculations of Novel Carboxylic Acid Analogs Containing Pyrrole and Imidazole Rings. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70163

BibTeX
@article{Abeysiriwardhana2025,
  author = {Abeysiriwardhana, Hiruni Nilshi Indeevarie and Choi, Jin-Hyuk and Malla, Ayusha and Lim, Yoongho and Park, Chulhun and Nahm, Sang-Soep and Cho, Moonjae},
  title = {Synthesis, Anti‐Fibrotic Activity, and Density Functional Theory Calculations of Novel Carboxylic Acid Analogs Containing Pyrrole and Imidazole Rings},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70163}
}
Kostenlos starten →